Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform.
about
Proteoliposome-based full-length ZnT8 self-antigen for type 1 diabetes diagnosis on a plasmonic platform.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@en
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@nl
type
label
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@en
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@nl
prefLabel
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@en
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@nl
P2093
P2860
P356
P1476
Proteoliposome-based full-leng ...... nosis on a plasmonic platform.
@en
P2093
Chengfeng Merriman
Clive H Wasserfall
Kieran M Mcgrail
Mark A Atkinson
Yongye Liang
P2860
P304
10196-10201
P356
10.1073/PNAS.1711169114
P407
P577
2017-09-05T00:00:00Z